Claybrook Capital, LLC Eli Lilly & CO Transaction History

Claybrook Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $429,904 - $529,057	-1,940 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$180.55 - $233.54 $350,267 - $453,067	1,940 New	1,940 $445,000
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $2,114 - $2,489	-19 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $2,012 - $2,254	19 New	19 $2,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Claybrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Claybrook Capital, LLC with notifications on news.